121 related articles for article (PubMed ID: 21387693)
21. Effect of atorvastatin therapy on fibrous cap thickness in coronary atherosclerotic plaque as assessed by optical coherence tomography: the EASY-FIT study.
Komukai K; Kubo T; Kitabata H; Matsuo Y; Ozaki Y; Takarada S; Okumoto Y; Shiono Y; Orii M; Shimamura K; Ueno S; Yamano T; Tanimoto T; Ino Y; Yamaguchi T; Kumiko H; Tanaka A; Imanishi T; Akagi H; Akasaka T
J Am Coll Cardiol; 2014 Dec; 64(21):2207-17. PubMed ID: 25456755
[TBL] [Abstract][Full Text] [Related]
22. High-dose atorvastatin is superior to moderate-dose simvastatin in preventing peripheral arterial disease.
Stoekenbroek RM; Boekholdt SM; Fayyad R; Laskey R; Tikkanen MJ; Pedersen TR; Hovingh GK;
Heart; 2015 Mar; 101(5):356-62. PubMed ID: 25595417
[TBL] [Abstract][Full Text] [Related]
23. A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis.
Kruger P; Bailey M; Bellomo R; Cooper DJ; Harward M; Higgins A; Howe B; Jones D; Joyce C; Kostner K; McNeil J; Nichol A; Roberts MS; Syres G; Venkatesh B;
Am J Respir Crit Care Med; 2013 Apr; 187(7):743-50. PubMed ID: 23348980
[TBL] [Abstract][Full Text] [Related]
24. A randomized placebo controlled trial of the effect of preoperative statin use on matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in areas of low and peak wall stress in patients undergoing elective open repair of abdominal aortic aneurysm.
Rahman MN; Khan JA; Mazari FA; Mockford K; McCollum PT; Chetter IC
Ann Vasc Surg; 2011 Jan; 25(1):32-8. PubMed ID: 20889295
[TBL] [Abstract][Full Text] [Related]
25. Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrolees? A non-randomized, observational, retrospective study.
Hussein MA; Chapman RH; Benner JS; Tang SS; Solomon HA; Joyce A; Foody JM
Am J Cardiovasc Drugs; 2010; 10(3):193-202. PubMed ID: 20387911
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.
Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y
JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994
[TBL] [Abstract][Full Text] [Related]
27. Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials).
Murphy SA; Cannon CP; Wiviott SD; de Lemos JA; Blazing MA; McCabe CH; Califf RM; Braunwald E
Am J Cardiol; 2007 Oct; 100(7):1047-51. PubMed ID: 17884359
[TBL] [Abstract][Full Text] [Related]
28. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial.
Patti G; Ricottini E; Nusca A; Colonna G; Pasceri V; D'Ambrosio A; Montinaro A; Di Sciascio G
Am J Cardiol; 2011 Jul; 108(1):1-7. PubMed ID: 21529740
[TBL] [Abstract][Full Text] [Related]
29. Can a high reloading dose of atorvastatin prior to percutaneous coronary intervention reduce periprocedural myocardial infarction?
Nafasi L; Rahmani R; Shafiee A; Salari A; Abdollahi A; Meysamie A
Curr Med Res Opin; 2014 Mar; 30(3):381-6. PubMed ID: 23952289
[TBL] [Abstract][Full Text] [Related]
30. Effects of atorvastatin on the Th1/Th2 polarization of ongoing experimental autoimmune myocarditis in Lewis rats.
Liu W; Li WM; Gao C; Sun NL
J Autoimmun; 2005 Dec; 25(4):258-63. PubMed ID: 16242301
[TBL] [Abstract][Full Text] [Related]
31. The effect of aggressive versus conventional lipid-lowering therapy on markers of inflammatory and oxidative stress.
Mulder DJ; van Haelst PL; Wobbes MH; Gans RO; Zijlstra F; May JF; Smit AJ; Tervaert JW; van Doormaal JJ
Cardiovasc Drugs Ther; 2007 Apr; 21(2):91-7. PubMed ID: 17342417
[TBL] [Abstract][Full Text] [Related]
32. Effect of withdrawal of statin on C-reactive protein.
Lee KT; Lai WT; Chu CS; Tsai LY; Yen HW; Voon WC; Sheu SH
Cardiology; 2004; 102(3):166-70. PubMed ID: 15334028
[TBL] [Abstract][Full Text] [Related]
33. Statin treatment decreased serum asymmetric dimethylarginine (ADMA) levels in ischemic stroke patients.
Nishiyama Y; Ueda M; Otsuka T; Katsura K; Abe A; Nagayama H; Katayama Y
J Atheroscler Thromb; 2011; 18(2):131-7. PubMed ID: 21081834
[TBL] [Abstract][Full Text] [Related]
34. Reduction in serum levels of adhesion molecules, interleukin-6 and C-reactive protein following short-term low-dose atorvastatin treatment in patients with non-familial hypercholesterolemia.
Nawawi H; Osman NS; Yusoff K; Khalid BA
Horm Metab Res; 2003 Aug; 35(8):479-85. PubMed ID: 12953165
[TBL] [Abstract][Full Text] [Related]
35. Comparative effects of high-dose atorvastatin versus moderate-dose rosuvastatin on lipid parameters, oxidized-LDL and inflammatory markers in ST elevation myocardial infarction.
Aydin MU; Aygul N; Altunkeser BB; Unlu A; Taner A
Atherosclerosis; 2015 Apr; 239(2):439-43. PubMed ID: 25697576
[TBL] [Abstract][Full Text] [Related]
36. A randomized placebo controlled trial of early treatment of acute ischemic stroke with atorvastatin and irbesartan.
Beer C; Blacker D; Bynevelt M; Hankey GJ; Puddey IB
Int J Stroke; 2012 Feb; 7(2):104-11. PubMed ID: 22044557
[TBL] [Abstract][Full Text] [Related]
37. Continuation of statin therapy in patients with presumed infection: a randomized controlled trial.
Kruger PS; Harward ML; Jones MA; Joyce CJ; Kostner KM; Roberts MS; Venkatesh B
Am J Respir Crit Care Med; 2011 Mar; 183(6):774-81. PubMed ID: 20959555
[TBL] [Abstract][Full Text] [Related]
38. [The statin dosage for achieving goal of cholesterol-lowering based on risk stratification in patients with ischemic cerebrovascular diseases].
Tan ZF; Guo YD; Xu AD; Yang WY; Fu YG; Wang TG
Zhonghua Nei Ke Za Zhi; 2009 Apr; 48(4):280-3. PubMed ID: 19576114
[TBL] [Abstract][Full Text] [Related]
39. Long-term effects of ezetimibe-plus-statin therapy on low-density lipoprotein cholesterol levels as compared with double-dose statin therapy in patients with coronary artery disease.
Okada K; Iwahashi N; Endo T; Himeno H; Fukui K; Kobayashi S; Shimizu M; Iwasawa Y; Morita Y; Wada A; Shigemasa T; Mochida Y; Shimizu T; Sawada R; Uchino K; Umemura S; Kimura K
Atherosclerosis; 2012 Oct; 224(2):454-6. PubMed ID: 22892323
[TBL] [Abstract][Full Text] [Related]
40. The atorvastatin during ischemic stroke study: a pilot randomized controlled trial.
Muscari A; Puddu GM; Santoro N; Serafini C; Cenni A; Rossi V; Zoli M
Clin Neuropharmacol; 2011; 34(4):141-7. PubMed ID: 21677574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
